Skip to main content
Relationshipslibidosexual healthvaginal dryness

Changes in Sex Drive During Menopause: What's Normal and What Helps

Changes in libido, vaginal comfort, and sexual function are common in perimenopause and menopause — and highly treatable. Here's an honest, evidence-based look.

Published 6 min read

Sexuality in midlife is often discussed in hushed tones — or not at all. Many women experience significant changes in libido and sexual comfort during perimenopause and menopause, but feel embarrassed to raise it with their providers or partners, assuming it's simply an inevitable and untreatable part of aging.

It isn't. These changes are well understood, have identifiable causes, and are highly responsive to treatment.

Key Takeaways

  • Changes in libido and sexual function are common in menopause but are not inevitable long-term
  • Multiple hormonal factors contribute: declining estrogen, testosterone, and the physical effects on vaginal tissue
  • Genitourinary Syndrome of Menopause (GSM) — vaginal dryness, irritation, and pain — is distinct from and may compound low desire
  • Non-hormonal options (lubricants, moisturizers, pelvic floor physical therapy) are effective for many women
  • Local vaginal estrogen is highly effective for GSM with minimal systemic absorption
  • Testosterone therapy for low sexual desire in women is used off-label in the US and has emerging evidence

The Hormonal Landscape

Sexual desire and function involve a complex interplay of hormones, neurotransmitters, psychological factors, and relationship dynamics. In menopause, several hormonal changes converge:

Estrogen decline affects vaginal tissue directly — leading to thinning of vaginal walls, decreased natural lubrication, and changes in elasticity and pH. These physical changes can make intercourse uncomfortable or painful.

Testosterone, while present in women at much lower levels than in men, plays a role in sexual desire. Testosterone declines gradually throughout a woman's reproductive years and continues declining after menopause. The relationship between testosterone levels and desire is less straightforward in women than in men, but it is clinically meaningful for some.

Progesterone shifts may contribute to mood changes that affect sexual interest indirectly.

Genitourinary Syndrome of Menopause (GSM)

Previously termed "vulvovaginal atrophy" (VVA), Genitourinary Syndrome of Menopause is now the preferred clinical term because it more accurately captures the range of symptoms: vaginal dryness, irritation, burning, discomfort with penetration, recurrent urinary tract infections, and urinary urgency.

GSM affects an estimated 40–60% of postmenopausal women, but only a fraction seek treatment. Unlike vasomotor symptoms (hot flashes), which often improve over time without treatment, GSM tends to progress and worsen without intervention.

GSM and low libido are related but distinct conditions. Painful or uncomfortable sex can cause or worsen low desire — but some women experience low desire independently of vaginal discomfort. Understanding the distinction helps guide treatment.

Portman DJ, Gass ML. (2014). "Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The Menopause Society." Menopause, 21(10), 1063–1068.

Non-Hormonal Options for GSM

Vaginal lubricants: Used at the time of sexual activity to reduce friction and discomfort. Water-based or silicone-based lubricants are safe with condoms. Silicone-based last longer. Oil-based products should not be used with latex condoms.

Vaginal moisturizers: Applied regularly (not just during sex) to maintain vaginal hydration and pH. Products like Replens are used 2–3 times per week. These are distinct from lubricants.

Pelvic floor physical therapy: Highly effective for women with pelvic floor dysfunction, which is common in menopause. A specialized physical therapist can address muscle tension, weakness, and coordination issues that affect sexual comfort.

Local Vaginal Estrogen

Low-dose, locally applied estrogen — available as creams, tablets, rings, or suppositories — is highly effective for GSM. Unlike systemic estrogen, vaginal estrogen is applied directly to the target tissue, resulting in minimal systemic absorption.

Current evidence indicates that local vaginal estrogen does not carry the same systemic risks as oral or transdermal estrogen — it can be used by many women who cannot use systemic HRT, including most breast cancer survivors (though this should be confirmed with an oncologist).

ACOG Committee on Practice Bulletins. (2020). "The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer." ACOG Committee Opinion No. 659.

Addressing Low Sexual Desire

Systemic hormone therapy — if appropriate for vasomotor symptoms — may also improve libido for some women by addressing the hormonal environment more broadly and by improving sleep and mood.

Testosterone therapy: No testosterone product is currently FDA-approved specifically for women in the United States. However, testosterone therapy is used off-label for women with Hypoactive Sexual Desire Disorder (HSDD), and several major medical societies support its use in selected women with thorough risk-benefit discussion. Evidence from clinical trials and meta-analyses suggests it can improve sexual desire, satisfaction, and frequency when properly indicated.

Testosterone therapy in women requires careful monitoring of hormone levels and is associated with potential side effects including acne, unwanted hair growth, and voice changes at higher doses. Discuss this with a provider who is knowledgeable about women's hormonal health.

Psychosocial factors: Sexual desire is strongly influenced by relationship dynamics, stress, body image, mental health, and prior experiences. These factors don't disappear with a prescription and often benefit from attention alongside medical treatment — whether through couples counseling, individual therapy, or sex therapy.

Frequently Asked Questions

You don't have to navigate these changes alone

ByAven providers can evaluate what's driving your symptoms and discuss treatment options — hormonal and non-hormonal — in a judgment-free setting.

Start your assessment

Medical Disclaimer

This article is for educational and informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating a health problem or disease. Always consult a licensed healthcare provider before making any medical decisions or changes to your treatment plan. Individual results may vary. Read our full medical disclaimer.

Share

Related articles

ByAven Journal

Evidence-based menopause guidance, in your inbox

New articles, research summaries, and provider insights — no spam, no product pitches.

Unsubscribe anytime. We never share your email.

Take the first step toward feeling like yourself again.

Personalized menopause care, designed by experts. Start with our free assessment.